Extracellular Vesicles in Advanced Prostate Cancer: Tools to Predict and Thwart Therapeutic Resistance

Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death among men worldwide. At first, advanced PCa is treated by androgen deprivation therapy with a good initial response. Nevertheless, recurrences occur, leading to Castrate-Resistance Prostate Cancer (C...

Full description

Bibliographic Details
Main Authors: Carolina Saldana, Amene Majidipur, Emma Beaumont, Eric Huet, Alexandre de la Taille, Francis Vacherot, Virginie Firlej, Damien Destouches
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/15/3791